Inventor · disambiguated record
James Breitenbucher
Also filed as: BREITENBUCHER JAMES · BREITENBUCHER JAMES G · BREITENBUCHER JAMES GUY
20 granted patents·12 pending applications·155 citations·filing 1998–2024
93Inventor score
Files withDART NEUROSCIENCE CAYMAN LTD15DART NEUROSCIENCE LLC5GENENTECH INC3BRANSTETTER BRYAN JAMES2BRISTOL MYERS SQUIBB CO2
Top patents by PatentIndex Score
32 records- 0194US9175010B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6H)-onesDART NEUROSCIENCE CAYMAN LTD·Filed 2013·Granted Nov 3, 2015·12 cites·17 claims
- 0293US6001836ADihydropyridine NPY antagonists: cyanoguanidine derivativesBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Dec 14, 1999·98 cites·8 claims
- 0388US9932345B2Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2015·Granted Apr 3, 2018·3 cites·35 claims
- 0487US9533996B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-onesDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Jan 3, 2017·3 cites·20 claims
- 0587US2025122172A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 0686US9499562B2Substituted thiophene- and furan-fused azolopyrimidine-5-(6H)-one compoundsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2013·Granted Nov 22, 2016·3 cites·27 claims
- 0785US8431704B2Quinoline or isoquinoline substituted P2X7 antagonistsLOVE CHRISTOPHER JOHN·Filed 2009·Granted Apr 30, 2013·24 cites·12 claims
- 0885US2025092047A1Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 0984US10092575B2Substituted thiophene- and furan-fused azolopyrimidine-5-(6H)-one compoundsDART NEUROSCIENCE CAYMAN LTD·Filed 2016·Granted Oct 9, 2018·3 cites·10 claims
- 1081US9120770B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted Sep 1, 2015·3 cites·30 claims
- 1179US10239882B2Substituted 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2015·Granted Mar 26, 2019·2 cites·20 claims
- 1279US2023075774A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Application pending·0 cites
- 1378US11186582B2Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2019·Granted Nov 30, 2021·0 cites·20 claims
- 1478US9040692B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted May 26, 2015·2 cites·1 claims
- 1577US2023192698A1Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Application pending·0 cites
- 1676US7723527B2Benzoimidazole compoundsJANSSEN PHARMACEUTICA NV·Filed 2008·Granted May 25, 2010·1 cites·24 claims
- 1774US9573937B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Feb 21, 2017·1 cites·20 claims
- 1873US11279691B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE LLC·Filed 2019·Granted Mar 22, 2022·0 cites·4 claims
- 1971US10376514B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6H)-onesDART NEUROSCIENCE CAYMAN LTD·Filed 2018·Granted Aug 13, 2019·0 cites·20 claims
- 2068US2024391930A1Spirocyclic bicyclic modulators of cholesterol biosynthesis and their use for promoting remyelinationGENENTECH INC·Filed 2024·Application pending·0 cites
- 2167US2024400579A1Spirocyclic modulators of cholesterol biosynthesis and their use for promoting remyelinationGENENTECH INC·Filed 2024·Application pending·0 cites
- 2267US2024398781A1Spirocyclic cyclic modulators of cholesterol biosynthesis and their use for promoting remyelinationGENENTECH INC·Filed 2024·Application pending·0 cites
- 2365US2018346448A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2018·Application pending·0 cites
- 2464US2016009691A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Application pending·0 cites
- 2562US10105367B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-onesDART NEUROSCIENCE CAYMAN LTD·Filed 2016·Granted Oct 23, 2018·0 cites·20 claims
- 2661US10501465B2Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2018·Granted Dec 10, 2019·0 cites·22 claims
- 2757US8673895B2Tetrahydro-pyrimidoazepines as modulators of TRPV1BRANSTETTER BRYAN JAMES·Filed 2007·Granted Mar 18, 2014·0 cites·12 claims
- 2854US12098145B2Oxazole TRPML1 agonists and uses thereofLIBRA THERAPEUTICS INC·Filed 2023·Granted Sep 24, 2024·0 cites·26 claims
- 2952US2024254083A1Heterocyclic trpml1 agonists and uses thereofLIBRA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3045US2008004253A1Thiazolopyrimidine modulators of TRPV1BRANSTETTER BRYAN JAMES·Filed 2007·Application pending·0 cites
- 3143US2010292266A1Oxazolyl Piperidine Modulators of Fatty Acid Amide HydrolaseAPODACA RICHARD·Filed 2007·Application pending·0 cites
- 3239US6596724B2Oxadiazole and thiadiazole derivatives of dihydropyridine NPY antagonistsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jul 22, 2003·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →